Approved for Prevention of herpes zoster (shingles) in adults 50 years of age and older, Prevention of herpes zoster in adults 18 years and older who are or will be at increased risk of shingles due to immunodeficiency or immunosuppression. Contains recombinant varicella-zoster virus glycoprotein E (gE) combined with the AS01B adjuvant system. The gE protein is the most abundant glycoprotein on…
Loading full data from Know Your Drugs Institute…